Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 69 Records) |
| Query Trace: Melanoma and CDK4[original query] |
|---|
| CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters. Acta dermato-venereologica 2018 May . Karagianni Fani, Njauw Ching-Ni, Kypreou Katerina P, Stergiopoulou Aravela, Plaka Michaela, Polydorou Dorothea, Chasapi Vasiliki, Pappas Leontios, Stratigos Ioannis A, Champsas Gregory, Panagiotou Peter, Gogas Helen, Evangelou Evangelos, Tsao Hensin, Stratigos Alexander J, Stefanaki Ire |
| The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas. Cancer 2018 12 125 (4): 586-600. Appenzeller Silke, Gesierich Anja, Thiem Alexander, Hufnagel Anita, Jessen Christina, Kneitz Hermann, Regensburger Martina, Schmidt Cornelia, Zirkenbach Vanessa, Bischler Thorsten, Schilling Bastian, Siedel Claudia, Goebeler Maria-Elisabeth, Houben Roland, Schrama David, Gehrig Andrea, Rost Simone, Maurus Katja, Bargou Ralf, Rosenwald Andreas, Schartl Manfred, Goebeler Matthias, Meierjohann Sven |
| POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families. The British journal of dermatology 2019 Jul 181 (1): 105-113. Potrony M, Puig-Butille J A, Ribera-Sola M, Iyer V, Robles-Espinoza C D, Aguilera P, Carrera C, Malvehy J, Badenas C, Landi M T, Adams D J, Puig |
| Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families. International journal of cancer 2018 11 144 (10): 2453-2464. Potjer Thomas P, Bollen Sander, Grimbergen Anneliese J E M, van Doorn Remco, Gruis Nelleke A, van Asperen Christi J, Hes Frederik J, van der Stoep Nienke, |
| Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 8 25 (21): 6511-6523. Yu Jiayi, Yan Junya, Guo Qian, Chi Zhihong, Tang Bixia, Zheng Bin, Yu Jinyu, Yin Ting, Cheng Zhiyuan, Wu Xiaowen, Yu Huan, Dai Jie, Sheng Xinan, Si Lu, Cui Chuanliang, Bai Xue, Mao Lili, Lian Bin, Wang Xuan, Yan Xieqia, Li Siming, Zhou Li, Flaherty Keith T, Guo Jun, Kong Y |
| Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families. The Journal of investigative dermatology 2019 7 140 (1): 174-181.e3. Sargen Michael R, Pfeiffer Ruth M, Yang Xiaohong R, Tucker Margaret A, Goldstein Alisa |
| Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets. Nature communications 2019 7 10 (1): 3163. Newell Felicity, Kong Yan, Wilmott James S, Johansson Peter A, Ferguson Peter M, Cui Chuanliang, Li Zhongwu, Kazakoff Stephen H, Burke Hazel, Dodds Tristan J, Patch Ann-Marie, Nones Katia, Tembe Varsha, Shang Ping, van der Weyden Louise, Wong Kim, Holmes Oliver, Lo Serigne, Leonard Conrad, Wood Scott, Xu Qinying, Rawson Robert V, Mukhopadhyay Pamela, Dummer Reinhard, Levesque Mitchell P, Jönsson Göran, Wang Xuan, Yeh Iwei, Wu Hong, Joseph Nancy, Bastian Boris C, Long Georgina V, Spillane Andrew J, Shannon Kerwin F, Thompson John F, Saw Robyn P M, Adams David J, Si Lu, Pearson John V, Hayward Nicholas K, Waddell Nicola, Mann Graham J, Guo Jun, Scolyer Richard |
| A novel CDKN2A variant (p16 ) in a patient with familial and multiple primary melanomas. Pigment cell & melanoma research 2019 4 32 (5): 734-738. Li Christopher, Liu Tong, Liu Bin, Hernandez Rolando, Facelli Julio C, Grossman Dougl |
| Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants. Melanoma research 2019 Sep . Li Christopher, Liu Tong, Tavtigian Sean V, Boucher Kenneth, Kohlmann Wendy, Cannon-Albright Lisa, Grossman Dougl |
| A novel CDKN2A in-frame deletion associated with pancreatic cancer-melanoma syndrome. Dermatology online journal 2020 9 26 (8): . Bottillo Irene, Valiante Michele, Menale Lucia, Paiardini Alessandro, Papi Laura, Janson Giacomo, Sestini Roberta, Iorio Alessandra, De Simone Paola, Frascione Pasquale, Grammatico Pao |
| Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients. Cancers 2020 8 12 (9): . Hilke Franz J, Sinnberg Tobias, Gschwind Axel, Niessner Heike, Demidov German, Amaral Teresa, Ossowski Stephan, Bonzheim Irina, Röcken Martin, Riess Olaf, Garbe Claus, Schroeder Christopher, Forschner Andr |
| Melanoma Genomics. Acta dermato-venereologica 2020 4 100 (11): adv00138. Newton-Bishop Julia, Bishop D Timothy, Harland Ma |
| Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1. Cancers 2020 Apr 12 (4): . Pastorino Lorenza, Andreotti Virginia, Dalmasso Bruna, Vanni Irene, Ciccarese Giulia, Mandalà Mario, Spadola Giuseppe, Pizzichetta Maria Antonietta, Ponti Giovanni, Tibiletti Maria Grazia, Sala Elena, Genuardi Maurizio, Chiurazzi Pietro, Maccanti Gabriele, Manoukian Siranoush, Sestini Serena, Danesi Rita, Zampiga Valentina, Starza Roberta La, Stanganelli Ignazio, Ballestrero Alberto, Mastracci Luca, Grillo Federica, Sciallero Stefania, Cecchi Federica, Tanda Enrica Teresa, Spagnolo Francesco, Queirolo Paola, Imi Italian Melanoma Intergroup, Goldstein Alisa M, Bruno William, Ghiorzo Pao |
| Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain. Journal of the American Academy of Dermatology 2020 4 83 (3): 860-869. Sargen Michael R, Calista Donato, Elder David E, Massi Daniela, Chu Emily Y, Potrony Míriam, Pfeiffer Ruth M, Carrera Cristina, Aguilera Paula, Alos Llucia, Puig Susana, Elenitsas Rosalie, Yang Xiaohong R, Tucker Margaret A, Landi Maria Teresa, Goldstein Alisa |
| Clinical histopathological features and CDKN2A/CDK4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaic. Italian journal of dermatology and venereology 2020 Mar . Dika Emi, Patrizi Annalisa, Rossi Cesare, Turchetti Daniela, Miccoli Sara, Ferracin Manuela, Veronesi Giulia, Scarfì Federica, Lambertini Marti |
| A Single Center Retrospective Review of Patients from Central Italy Tested for Melanoma Predisposition Genes. International journal of molecular sciences 2020 Dec 21 (24): . De Simone Paola, Bottillo Irene, Valiante Michele, Iorio Alessandra, De Bernardo Carmelilia, Majore Silvia, D'Angelantonio Daniela, Valentini Tiziana, Sperduti Isabella, Piemonte Paolo, Eibenschutz Laura, Ferrari Angela, Carbone Anna, Buccini Pierluigi, Paiardini Alessandro, Silipo Vitaliano, Frascione Pasquale, Grammatico Pao |
| Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients. Scientific reports 2020 Oct 10 (1): 17687. Aoude Lauren G, Bonazzi Vanessa F, Brosda Sandra, Patel Kalpana, Koufariotis Lambros T, Oey Harald, Nones Katia, Wood Scott, Pearson John V, Lonie James M, Arneil Melissa, Atkinson Victoria, Smithers B Mark, Waddell Nicola, Barbour Andrew |
| Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy. Targeted oncology 2020 1 15 (1): 101-113. Olbryt Magdalena, Pig?owski Wojciech, Rajczykowski Marcin, Pfeifer Aleksandra, Student Sebastian, Fiszer-Kierzkowska An |
| Genetic markers for characterization and prediction of prognosis of melanoma subtypes: a 2021 update. Italian journal of dermatology and venereology 2021 5 156 (3): 322-330. Podlipnik Sebastian, Potrony Miriam, Puig Susa |
| The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of CDKN2A and CDK4. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2021 4 30 (4): 676-681. Sargen Michael R, Pfeiffer Ruth M, Elder David E, Yang Xiaohong R, Goldstein Alisa M, Tucker Margaret |
| 3'UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma. In vivo (Athens, Greece) 0 35 (3): 1529-1536. Tovar-Parra David, Gil-Quiñones Sebastián Ramiro, Nova John, Gutiérrez-Castañeda Luz |
| Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma. Molecular cancer research : MCR 2021 3 19 (6): 991-1004. Broit Natasa, Johansson Peter A, Rodgers Chloe B, Walpole Sebastian T, Newell Felicity, Hayward Nicholas K, Pritchard Antonia |
| Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients. Journal of the European Academy of Dermatology and Venereology : JEADV 2021 10 36 (2): 213-221. Pellegrini C, Raimondi S, Di Nardo L, Ghiorzo P, Menin C, Manganoni M A, Palmieri G, Guida G, Quaglino P, Stanganelli I, Massi D, Pastorino L, Elefanti L, Tosti G, Queirolo P, Leva A, Maurichi A, Rodolfo M, Fargnoli M C, |
| Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup. ESMO open 2022 7 7 (4): 100525. Bruno W, Dalmasso B, Barile M, Andreotti V, Elefanti L, Colombino M, Vanni I, Allavena E, Barbero F, Passoni E, Merelli B, Pellegrini S, Morgese F, Danesi R, Calò V, Bazan V, D'Elia A V, Molica C, Gensini F, Sala E, Uliana V, Soma P F, Genuardi M, Ballestrero A, Spagnolo F, Tanda E, Queirolo P, Mandalà M, Stanganelli I, Palmieri G, Menin C, , Pastorino L, Ghiorzo |
| Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (14): 3002-3010. Schuler Martin, Zimmer Lisa, Kim Kevin B, Sosman Jeffrey A, Ascierto Paolo A, Postow Michael A, De Vos Filip Y F L, van Herpen Carla M L, Carlino Matteo S, Johnson Douglas B, Berking Carola, Reddy Micaela B, Harney Allison S, Berlin Jordan D, Amaria Rodabe |
| Systematic review and meta-analysis of genomic alterations in acral melanoma. Pigment cell & melanoma research 2022 3 35 (3): 369-386. Broit Natasa, Johansson Peter A, Rodgers Chloe B, Walpole Sebastian T, Hayward Nicholas K, Pritchard Antonia |
| Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families. PloS one 2022 1 17 (1): e0262419. Fidalgo Felipe, Torrezan Giovana Tardin, Sá Bianca Costa Soares de, Barros Bruna Durães de Figueiredo, Moredo Luciana Facure, Valieris Renan, de Souza Sandro J, Duprat João Pereira, Krepischi Ana Cristina Victorino, Carraro Dirce Mar |
| High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: a multicenter cohort from the MelaNostrum Consortium. Journal of the European Academy of Dermatology and Venereology : JEADV 2023 8 . C Pellegrini, L Cardelli, P Ghiorzo, L Pastorino, M Potrony, Z García-Casado, L Elefanti, I Stefanaki, M Mastrangelo, S Necozione, P Aguilera, A Rodríguez-Hernández, L Di Nardo, T Rocco, L Del Regno, C Badenas, C Carrera, J Malvehy, C Requena, J Bañuls, A J Stratigos, K Peris, C Menin, D Calista, E Nagore, S Puig, M T Landi, M C Fargno |
| Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma. Journal of translational medicine 2023 2 21 (1): 78. Huang Rong, Shen Gaigai, Ren Yu, Zheng Kelin, Wang Jiayu, Shi Yan, Yin Jiani C, Qin Lanqun, Zhang Guiying, Zhao Mengke, Su Xinyu, Li Luqiao, Wang Fufeng, Shao Yang, Liu Baorui, Zou Zhengy |
| Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma. Computers in biology and medicine 2023 1 154 106602. Moon SeongRyeol, Kim Hee Joo, Lee Yeeun, Lee Yu Joo, Jung Sungwon, Lee Jin Sook, Hahn Si Houn, Kim Kyungdoc, Roh Joo Young, Nam Seungyo |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: